Stay updated on Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial
Sign up to get notified when there's something new on the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page.

Latest updates to the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page
- CheckyesterdayChange DetectedRevision label updated from v3.5.3 to v3.5.4 in the page history. This represents a minor maintenance update to the page's documentation and history log.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedUpdated the page’s revision identifier from v3.5.2 to v3.5.3 in the footer, indicating a site/viewer software update rather than a change to the underlying clinical trial record.SummaryDifference0.1%

- Check29 days agoChange DetectedAdded Revision: v3.5.2 to the history; removed Revision: v3.5.0.SummaryDifference0.1%

- Check58 days agoChange DetectedA new revision entry v3.5.0 was added to the history, and the previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check72 days agoChange DetectedA new revision entry v3.4.3 was added to the history and the previous entry v3.4.2 was removed from the revision log.SummaryDifference0.1%

- Check87 days agoChange Detected- Added a new Study Status entry in the record history (version 37, dated 2026-01-30). - Deleted the 2025-10-29 entry from the history.SummaryDifference0.3%

Stay in the know with updates to Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezo/Chemo +/- Tiragolumab in Untreated ES-SCLC Clinical Trial page.